SLC30A9
Proton-coupled zinc antiporter SLC30A9, mitochondrial
Also known as: C4orf1, GAC63, HUEL, ZNT9, ZNT9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PML9
- Gene
- SLC30A9
- Ensembl
- ENSG00000014824
- Chromosome
- 4
- Canonical length
- 568 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Enables zinc ion transmembrane transporter activity. Involved in intracellular zinc ion homeostasis; regulation of mitochondrion organization; and zinc ion transport. Located in several cellular components, including cytoplasmic vesicle; endoplasmic reticulum; and mitochondrial membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
568 residues, UniProt reviewed canonical sequence.
>Q6PML9|SLC30A9
1 MLPGLAAAAA HRCSWSSLCR LRLRCRAAAC NPSDRQEWQN LVTFGSFSNM VPCSHPYIGT
61 LSQVKLYSTN VQKEGQGSQT LRVEKVPSFE TAEGIGTELK APLKQEPLQV RVKAVLKKRE
121 YGSKYTQNNF ITGVRAINEF CLKSSDLEQL RKIRRRSPHE DTESFTVYLR SDVEAKSLEV
181 WGSPEALARE KKLRKEAEIE YRERLFRNQK ILREYRDFLG NTKPRSRTAS VFFKGPGKVV
241 MVAICINGLN CFFKFLAWIY TGSASMFSEA IHSLSDTCNQ GLLALGISKS VQTPDPSHPY
301 GFSNMRYISS LISGVGIFMM GAGLSWYHGV MGLLHPQPIE SLLWAYCILA GSLVSEGATL
361 LVAVNELRRN ARAKGMSFYK YVMESRDPST NVILLEDTAA VLGVIIAATC MGLTSITGNP
421 LYDSLGSLGV GTLLGMVSAF LIYTNTEALL GRSIQPEQVQ RLTELLENDP SVRAIHDVKA
481 TDLGLGKVRF KAEVDFDGRV VTRSYLEKQD FDQMLQEIQE VKTPEELETF MLKHGENIID
541 TLGAEVDRLE KELKKRNPEV RHVDLEILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC30A9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- kidney: 29 nTPM
- parathyroid gland: 21 nTPM
- heart muscle: 20 nTPM
- tongue: 19 nTPM
- retina: 18 nTPM
- cerebral cortex: 18 nTPM
Single-cell type
- somatotrophs: 229 nCPM
- lactotrophs: 216 nCPM
- thyrotrophs: 181 nCPM
- renal collecting duct intercalated cells: 172 nCPM
- myonuclei: 159 nCPM
- corticotrophs: 158 nCPM
Immune cell
- basophil: 3 nTPM
- myeloid DC: 2.5 nTPM
- intermediate monocyte: 2.3 nTPM
- NK-cell: 2.1 nTPM
- non-classical monocyte: 1.9 nTPM
- classical monocyte: 1.8 nTPM
Brain region
- cerebral cortex: 23 nTPM
- basal ganglia: 22 nTPM
- choroid plexus: 21 nTPM
- hippocampal formation: 21 nTPM
- hypothalamus: 21 nTPM
- cerebellum: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC30A9.
Disease | AllUniProt
Conditions SLC30A9 is implicated in, by any mechanism.
- Birk-Landau-Perez syndrome (BILAPES) MIM:617595
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 101 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.85
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular zinc ion homeostasis
- nucleotide-excision repair
- positive regulation of transcription by RNA polymerase II
- regulation of mitochondrion organization
- zinc ion transport
Molecular functions
- antiporter activity
- chromatin binding
- nuclear receptor binding
- transcription coactivator activity
- zinc ion transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC30A9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC30A9 as an antibody target. Whether an autoantibody or antibody against SLC30A9 could matter depends on whether native SLC30A9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC30A9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC30A9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...